IDEAYA Biosciences (IDYA) EBIAT: 2020-2025
Historic EBIAT for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $119.2 million.
- IDEAYA Biosciences' EBIAT rose 330.11% to $119.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$115.7 million, marking a year-over-year increase of 35.07%. This contributed to the annual value of -$274.5 million for FY2024, which is 142.98% down from last year.
- As of Q3 2025, IDEAYA Biosciences' EBIAT stood at $119.2 million, which was up 191.51% from -$130.3 million recorded in Q4 2024.
- Over the past 5 years, IDEAYA Biosciences' EBIAT peaked at $119.2 million during Q3 2025, and registered a low of -$130.3 million during Q4 2024.
- Its 3-year average for EBIAT is -$29.8 million, with a median of -$34.0 million in 2023.
- Its EBIAT has fluctuated over the past 5 years, first plummeted by 1,799.07% in 2023, then spiked by 330.11% in 2025.
- Quarterly analysis of 5 years shows IDEAYA Biosciences' EBIAT stood at -$18.2 million in 2021, then tumbled by 32.88% to -$24.2 million in 2022, then tumbled by 40.30% to -$34.0 million in 2023, then slumped by 283.78% to -$130.3 million in 2024, then spiked by 330.11% to $119.2 million in 2025.
- Its last three reported values are $119.2 million in Q3 2025, -$130.3 million for Q4 2024, and -$51.8 million during Q3 2024.